Amelanotic melanoma in a kidney transplant patient: a rare case report
- PMID: 38680765
- PMCID: PMC11049583
- DOI: 10.1093/omcr/omae035
Amelanotic melanoma in a kidney transplant patient: a rare case report
Abstract
Immunosuppressed individuals face a significantly elevated risk of developing aggressive cutaneous malignancies, often surpassing the aggressiveness observed in immunocompetent counterparts. Our patient exhibited several risk factors associated with melanoma development in renal recipients, including skin type, sun exposure, and the duration of immunosuppression. The determination of staging holds paramount importance as it directly influences both prognosis and subsequent management. It is crucial to handle suspected lesions with caution in these patients to facilitate early melanoma detection and enhance overall prognosis.
© The Author(s) 2024. Published by Oxford University Press.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Collins L, Quinn A, Stasko T. Skin cancer and immunosuppression. Dermatol Clin 2019;37:83–94. - PubMed
-
- Stojkovic-Filipovic J, Kittler H. Dermatoscopy of amelanotic and hypomelanotic melanoma. J Dtsch Dermatol Ges 2014;12:467–72. - PubMed
-
- Nelson J, Alvey N, Bowman L, Schulte J, Segovia MC, McDermott J. et al. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation. Pharmacotherapy 2022;42:599–633. - PubMed
-
- Nalamwar R, Kharkar V, Mahajan S, Chikhalkar S, Khopkar U. Nodular amelanotic melanoma. Indian J Dermatol Venereol Leprol 2010;76:273–5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
